Childhood-onset systemic lupus erythematosus (cSLE) is a prototype of a multisystemic,
inflammatory, heterogeneous autoimmune condition. This disease is characterized by …

Remission is the established therapeutic goal for patients with systemic lupus
erythematosus (SLE) and is currently defined by the widely adopted Definition Of Remission …

Objectives To investigate the impact of remission and lupus low disease activity state
(LLDAS) on health-related quality of life (HRQoL) in systemic lupus erythematosus. Methods …

Objectives To derive and validate a definition of low disease activity (LDA) for SLE based on
the SLE Disease Activity Score (SLE-DAS), in a real-life multicentre cohort of SLE patients …

Abstract Systemic Lupus Erythematosus is a systemic autoimmune disease characterized by
a great heterogenicity in course and clinical manifestations. Although prognosis improved in …

Systemic lupus erythematosus (SLE) is a chronic complex systemic autoimmune disease
characterized by multiple autoantibodies and clinical manifestations, with the potential to …

Objectives To investigate whether self-reported EQ-5D full health state (FHS) after
therapeutic intervention for active systemic lupus erythematosus (SLE) is associated with a …

Background Belimumab, an anti-B-cell activating factor antibody, is approved for the
treatment of auto-antibody positive systemic lupus erythematosus with a high degree of …

Objectives To describe phenotypes and outcomes of extra-renal flares in SLE, to identify
clusters of extra-renal flares based on baseline features, and to develop a machine learning …

Tackling active disease to prevent damage accrual constitutes a major goal in the
management of patients with systemic lupus erythematosus (SLE). Patients with early onset …